M.J. Requena-Tapia

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer

Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Antonio J. Montero‐Hidalgo et al. · EBioMedicine · 2020 · 117 citations · Full text

Medicine, Molecular Biology, Oncology +14

Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer

Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Enrique Gómez‐Gómez et al. · Translational research · 2019 · 77 citations

Medicine, Molecular Biology, Oncology +16

Bladder Cancer in Spain 2011: Population Based Study

J.M. Cózar, Joan Palou, R.A. Medina López et al. · The Journal of Urology · 2013 · 52 citations

Medicine, Oncology, Urology +15

Prostate Cancer Patients–Negative Biopsy Controls Discrimination by Untargeted Metabolomics Analysis of Urine by LC-QTOF: Upstream Information on Other Omics

M.A. Fernández-Peralbo, Enrique Gómez‐Gómez, M. Calderón-Santiago et al. · Scientific Reports · 2016 · 42 citations · Full text

Medicine, Oncology, Urology +17

Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer

Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Antonio J. Montero‐Hidalgo et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17